Non-inferiority of Short-term Catheterization Following Fistula Repair Surgery
NCT ID: NCT01428830
Last Updated: 2015-01-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
524 participants
INTERVENTIONAL
2012-01-31
2013-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Presurgical Exercise on Hemodialysis Fistula Outcomes
NCT02205944
Clipped Versus Handsewn Arteriovenous Fistula Anastomosis
NCT01669850
Prefistula Forearm Exercise in Pts Requiring Chronic HD Therapy
NCT03988270
TREatment of Uretral STRICTure With Self-catheterization : Tolerance Evaluation
NCT03948009
Ultrasound to Predict Steal-Syndrome After Arteriovenous-Fistula Creation (UPSAC - Trial)
NCT01468506
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This facility-based, multi-center randomized controlled trial (RCT) will test the non-inferiority of short-term (7 day) urethral catheterization compared to longer-term (14 day) urethral catheterization in terms of predicting fistula repair breakdown. The primary outcome is fistula repair breakdown three months following fistula repair surgery as assessed by a urinary dye test, a routine practice in fistula repair services. t. Secondary outcomes will include repair breakdown one week following catheter removal, intermittent catheterization due to urinary retention and the occurrence of septic or febrile episodes, prolonged hospitalization (defined as a stay at the facility beyond one week following initial catheter removal related to an adverse event), catheter blockage, and self-reported residual incontinence. This study will be conducted among 507 women with simple fistula presenting at 8 study sites for fistula repair surgery over the course of 16-18 months at each site.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
7-day catheterization
7-day catheterization following fistula repair surgery
This group will have an indwelling urethral catheter for 7 days following fistula repair surgery.
14-day catheterization
14 day catheterization
This group will have an indwelling urethral catheter for 14 days following fistula repair surgery.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
7-day catheterization following fistula repair surgery
This group will have an indwelling urethral catheter for 7 days following fistula repair surgery.
14 day catheterization
This group will have an indwelling urethral catheter for 14 days following fistula repair surgery.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
* Have a closed fistula 7 days after surgery (i.e. at the time of randomization)
* Understand study procedures and requirements
* Agree to return to the facility for one follow-up visit three month after the date of surgery
* Provide informed consent to participate in the study or in the case of non-emancipated minors, both consent to the study and receive proxy consent to participate in the study
* Have no contraindications precluding their participation.
* Have a fistula that is determined to be "not simple" (i.e. intermediate or complex)
* Have a fistula that is radiation-induced, associated with cancer or due to lymphogranuloma venereum (These cases will be excluded because the healing process is very different from fistula resulting from other causes. We expect there to be few cases of these fistulas at the study sites)
* Have a fistula that is not closed immediately after surgery or 7 days after surgery (i.e. at the time of randomization)
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
World Health Organization
OTHER
United States Agency for International Development (USAID)
FED
EngenderHealth
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mark A Barone, DVM, MS
Role: PRINCIPAL_INVESTIGATOR
EngenderHealth
Mariana Widmer
Role: STUDY_DIRECTOR
World Health Organization
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Saint Joseph
Kinshasa, , Democratic Republic of the Congo
Gondar University Hospital
Gonder, , Ethiopia
L'Hôpital Préfectoral de Kissidougou
Kissidougou, , Guinea
Kenyatta National Hospital
Nairobi, , Kenya
National Obstetric Fistula Centre
Abakaliki, , Nigeria
Maternité Centrale de Zinder
Zinder, , Niger
Aberdeen Women's Centre
Freetown, , Sierra Leone
Kagando Hospital
Kasese District, , Uganda
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Barone MA, Widmer M, Arrowsmith S, Ruminjo J, Seuc A, Landry E, Barry TH, Danladi D, Djangnikpo L, Gbawuru-Mansaray T, Harou I, Lewis A, Muleta M, Nembunzu D, Olupot R, Sunday-Adeoye I, Wakasiaka WK, Landoulsi S, Delamou A, Were L, Frajzyngier V, Beattie K, Gulmezoglu AM. Breakdown of simple female genital fistula repair after 7 day versus 14 day postoperative bladder catheterisation: a randomised, controlled, open-label, non-inferiority trial. Lancet. 2015 Jul 4;386(9988):56-62. doi: 10.1016/S0140-6736(14)62337-0. Epub 2015 Apr 21.
Barone MA, Frajzyngier V, Arrowsmith S, Ruminjo J, Seuc A, Landry E, Beattie K, Barry TH, Lewis A, Muleta M, Nembunzu D, Olupot R, Sunday-Adeoye I, Wakasiaka WK, Widmer M, Gulmezoglu AM. Non-inferiority of short-term urethral catheterization following fistula repair surgery: study protocol for a randomized controlled trial. BMC Womens Health. 2012 Mar 20;12:5. doi: 10.1186/1472-6874-12-5.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A65783
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.